[PDF][PDF] Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club

G Sianos, GS Werner, AR Galassi, MI Papafaklis… - …, 2012 - researchgate.net
The EuroCTO club was established in December 2006. In 2007 it published its first
consensus document on the recanalisation of Chronic Total Occlusions (CTOs), aiming to …

European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

C Pristipino, H Sievert, F D'ascenzo… - European Heart …, 2019 - academic.oup.com
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review

EB Wu, ES Brilakis, K Mashayekhi… - Journal of the American …, 2021 - jacc.org
The authors developed a global chronic total occlusion crossing algorithm following 10
steps: 1) dual angiography; 2) careful angiographic review focusing on proximal cap …

[HTML][HTML] Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke

L Søndergaard, SE Kasner, JF Rhodes… - … England Journal of …, 2017 - Mass Medical Soc
Background The efficacy of closure of a patent foramen ovale (PFO) in the prevention of
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …

Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic …

NE Moat, P Ludman, MA De Belder… - Journal of the American …, 2011 - jacc.org
Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …

[HTML][HTML] Percutaneous closure of patent foramen ovale in cryptogenic embolism

B Meier, B Kalesan, HP Mattle… - … England Journal of …, 2013 - Mass Medical Soc
Background The options for secondary prevention of cryptogenic embolism in patients with
patent foramen ovale are administration of antithrombotic medications or percutaneous …

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin …

P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg… - The Lancet, 2018 - thelancet.com
Background We hypothesised that ticagrelor, in combination with aspirin for 1 month,
followed by ticagrelor alone, improves outcomes after percutaneous coronary intervention …

[HTML][HTML] Dual antiplatelet therapy after PCI in patients at high bleeding risk

M Valgimigli, E Frigoli, D Heg, J Tijssen… - … England Journal of …, 2021 - Mass Medical Soc
Background The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …

Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry

D Dvir, J Webb, S Brecker, S Bleiziffer, D Hildick-Smith… - Circulation, 2012 - Am Heart Assoc
Background—Transcatheter aortic valve-in-valve implantation is an emerging therapeutic
alternative for patients with a failed surgical bioprosthesis and may obviate the need for …

Transcatheter aortic valve implantation in failed bioprosthetic surgical valves

D Dvir, JG Webb, S Bleiziffer, M Pasic, R Waksman… - Jama, 2014 - jamanetwork.com
Importance Owing to a considerable shift toward bioprosthesis implantation rather than
mechanical valves, it is expected that patients will increasingly present with degenerated …